What can we learn from drug marketing efficiency?
Where this comes from
- Record sourced from PubMed, PMID 19050331.
- Also identified by DOI 10.1136/bmj.a2591 and PMC identifier 3230247.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The time it takes new drugs to penetrate the market is shrinking.<b> David Kao</b> suggests how drug companies’ techniques could be used to improve safety surveillance systems
Medical subject headings
- Drug Industry
- Marketing